Department of Neurology, Medical University of Vienna, Vienna, Austria.
Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
J Neural Transm (Vienna). 2021 Oct;128(10):1545-1550. doi: 10.1007/s00702-021-02358-4. Epub 2021 Jun 10.
This review honors Kurt Jellinger on his 90th birthday as one of the most outstanding neuropathologists, who has contributed immensely to neuroscience due to his vast experience and collection of excellently documented autopsy cases. Two of his many insightful reports are highlighted here. One report focuses on the pathogenesis of inflammatory demyelinating diseases and investigates the neuropathology in autopsy tissue of a patient, who developed an MS-like disease after repeated treatment with lyophilized bovine brain cells in 1958. More than 60 years later, after reinvestigation of the historic samples in 2015 and subsequent mRNA isolation, next generation sequencing and reconstruction of the antibody, we succeeded in identifying myelin oligodendrocyte glycoprotein (MOG) as the target antigen and provided the missing element between the pathomechanisms in classic EAE animal models and transfer of this disease process into humans. A second significant example of Kurt Jellinger's contribution to neuroscience was a report on the role of MS in the development of Alzheimer's disease (AD), which found that AD pathology is present to the same extent in demyelinated and non-demyelinated cortical areas in MS and the incidence for AD pathology in elderly MS patients is comparable to the normal-aging population. This indicates that chronic inflammation in the MS cortex alone does not significantly predispose to the development of cortical AD pathology. These and other findings were only possible due to the broad collection of extremely well-defined material established by Kurt Jellinger, which ultimately continues to contribute to translational neuroscience, even decades later.
值此 Kurt Jellinger 90 寿辰之际,谨以此文向他这位杰出的神经病理学家致敬,他拥有丰富的经验和精心记录的尸检案例,为神经科学做出了巨大贡献。本文重点介绍了他的两项重要研究。其中一项研究聚焦于炎症性脱髓鞘疾病的发病机制,通过对一名患者的尸检组织进行研究,该患者在 1958 年反复接受冻干牛脑细胞治疗后出现了类似多发性硬化症的疾病。60 多年后,我们在 2015 年重新研究了这些具有历史意义的样本,并随后进行了 mRNA 分离、下一代测序和抗体重建,成功鉴定出髓鞘少突胶质细胞糖蛋白(MOG)为靶抗原,为经典 EAE 动物模型中的发病机制与疾病在人类中的转移之间架起了桥梁。Kurt Jellinger 对神经科学的另一项重要贡献是关于多发性硬化症(MS)在阿尔茨海默病(AD)发展中的作用的报告,该报告发现 AD 病理在 MS 的脱髓鞘和非脱髓鞘皮质区域中同样存在,且老年 MS 患者 AD 病理的发生率与正常老龄化人群相当。这表明 MS 皮质中的慢性炎症本身并不会显著增加皮质 AD 病理的发生风险。这些和其他发现都得益于 Kurt Jellinger 广泛收集的、定义明确的材料,这些材料最终仍在为转化神经科学做出贡献,即使在几十年后也是如此。